Clinical Trials · NCT05670379
Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Vivani Medical, Inc
- Enrollment
- 24
- Start date
- Dec 2024
- Locations
- 1 site, Australia
- Primary endpoint
- Area under the plasma concentration-time curve (AUC)